ANSI certification expected soon
This article was originally published in The Gold Sheet
Irwin Silverstein, vice-president and chief executive officer of International Pharmaceutical Excipients Auditing Inc., said that he expects the organization's third-party audit program of excipient suppliers to be certified by the American National Standards Institute by "the end of the first quarter of this year." He expects certification to ensure greater legitimacy - and acceptance - of IPEA's audit program among the pharmaceutical industry and FDA. He noted that "we're starting to gain more acceptance" with respect to third-party review of excipient suppliers. "2009 was a good year for the third-party certification program, it was a successful year." Silverstein further noted that "I think the agency sees the handwriting on the wall" with respect to third-party certification. "We think FDA will accept ANSI accreditation. The agency is one of the final arbiters. If ANSI says we have a good system, so should FDA." IPEA provides third-party audits of excipient manufacturers and auditor training and is an independent subsidiary of IPEC-Americas
You may also be interested in...
October and November 2020 were bad months for companies seeking to have their planned EU filings fast-tracked through the centralized drug review system at the European Medicines Agency.
Tactic aims to allow incoming Administration to scrutinize so-called ‘midnight rules’ issued in the final days of the Trump Administration before they take effect. Regulators may also solicit stakeholder comments on delayed rules.
Device companies operating in Canada are being advised to review their internal procedures in anticipation of new postmarket requirements that come into force this year.